TORNTPHARMNSETorrent Pharmaceuticals Limited· PharmaceuticalsLowNeutral
Announced Tue, 20 May · 19:25 IST

Torrent Pharmaceuticals Limited has informed the Exchange about Link of Recording

Investor Communications View source PDF

TORNTPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Torrent Pharmaceuticals has shared the audio recording link of its conference call held with analysts and investors to discuss the audited financial results for the quarter and year ended 31st March 2025. The recording has been placed on the company's website at torrentpharma.com. This is a routine SEBI compliance filing under Regulation 30(6) following the earlier intimation dated 13 May 2025. The filing itself does not contain any new financial figures, guidance, or strategic updates.

Likely market impact

No direct impact on shareholders or stock price — this is a standard procedural disclosure. Investors interested in management commentary on FY25 results can now listen to the recorded call for any forward-looking statements or guidance.